Core needle biopsy of the right breast mass confirmed invasive carcinoma of no special type with estrogen receptor (ER: 0%), progesterone receptor (PR: <1%), human epidermal growth factor receptor 2 (Her-2/Neu positive: 90%), and Ki-67 (80%) (Fig. 1). This evidence concerns the gene ERBB2 and invasive carcinoma.